PROMONTORY THERAPEUTICS

promontory-therapeutics-logo

Promontory Therapeutics Inc. is a clinical stage pharmaceutical company developing small molecule immunotherapies. The company's lead candidate, PT-112, is a novel chemical entity under clinical development that exhibits a unique combination of properties, including immunogenic cell death as well as osteotropism that confers advantages in dealing with cancers that originate in or metastasize to the bone. Clinical data generated to date across three Phase 1 studies have demonstrated single-agent ... anti-cancer activity and an attractive tolerability pro๏ฌle, and three Phase 2 studies of PT-112 are underway. The company also sponsors the ongoing clinical study of PT-112 in combination with the PD-L1 inhibitor avelumab under a collaboration agreement with P๏ฌzer and Merck KGaA, Darmstadt, Germany (operating as EMD Serono in the US and Canada), and has an active collaborative research and development agreement (CRADA) with the NCI to conduct a Phase 2 trial utilizing PT-112 in thymic epithelial tumors.

#SimilarOrganizations #People #Financial #Website #More

PROMONTORY THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2010-11-15

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.promontorytx.com

Total Employee:
1+

Status:
Active

Contact:
+1 646 380-2441

Email Addresses:
[email protected]

Total Funding:
72.01 M USD

Technology used in webpage:
SPF Amazon Organization Schema Google Apps For Business GoDaddy DNS AWS Global Accelerator


Similar Organizations

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Employees Featured

robert-e-fallon_image

Robert E. Fallon
Robert E. Fallon President, CEO and co-Founder @ Promontory Therapeutics
President, CEO and co-Founder

Founder


robert-e-fallon_image

Robert E. Fallon

Investors List

adinvest-ag_image

Adinvest AG

Adinvest AG investment in Series A - Promontory Therapeutics

Official Site Inspections

http://www.promontorytx.com Semrush global rank: 1.08 M Semrush visits lastest month: 30.48 K

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Promontory Therapeutics" on Search Engine